Vaccinations and People With Disabilities
Questionnaires and Focus Groups Based Quantitative & Qualitative Study of Vaccine Hesitancy and Confidence Among At-risk and Marginalized Populations: Persons With Special Needs, Intellectual Disabilities and Congenital Anomalies
1 other identifier
observational
1,000
1 country
1
Brief Summary
The goal of this observational study is to learn about vaccinations hesitancy, delay or avoidance in children with chronic diseases, congenital anomalies or disabilities. The main questions it aims to answer are: • Attitudes of caregivers towards vaccinating their children, obstacles that postpone vaccinations, and the status of vaccinations of these children. Participants will fill out questionnaires and some will be included in focused groups for the qualitative part of the study. Researchers will compare the vaccinations status of the research group to their siblings' status as well as the published national records of vaccination compliance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 8, 2023
CompletedFirst Posted
Study publicly available on registry
March 1, 2023
CompletedStudy Start
First participant enrolled
July 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedApril 3, 2025
September 1, 2024
2.5 years
February 8, 2023
April 1, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Percentages of children in the study group who are not vaccinated, partially vaccinated, or vaccinated late, in comparison with the percentages in the control group.
Percecntages as described above as well as description of reasons for vaccination avoidance, delay and hesitancy, obstacles in the way to vaccinate, approach to vaccines as detaled in the questionnaires.
2 years
Study Arms (1)
study group and control group
Study group - children with chronic diseases, disabilities, or congenital anomalies. Control group - their siblings.
Eligibility Criteria
Children with disabilities, chronic conditions and congenital anomalies. The parents will fiil out the questionnaires and participate in focus groups.
You may qualify if:
- Diagnosed children with disabilities, chronic diseases or congenital anomalies
You may not qualify if:
- Undiagnosed children
- Inadequate filled out questionnaires
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hadassah Medical Organizationlead
- Merck Sharp & Dohme LLCcollaborator
Study Sites (1)
Hadassah medical center
Jerusalem, 92140, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ariel Tenenbaum, MD
Hadassah Medical Organization
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- FAMILY BASED
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator, MD, Clinical Professor, Director of the center for children with chronic diseases
Study Record Dates
First Submitted
February 8, 2023
First Posted
March 1, 2023
Study Start
July 1, 2023
Primary Completion
January 1, 2026
Study Completion
January 1, 2026
Last Updated
April 3, 2025
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share